Semler Scientific Inc (SMLR, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Semler Scientific Inc is a medical risk-assessment company. It develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases. Its products include QuanataFlo and WellChec. Semler Scientific Inc has a market cap of $306.820 million; its shares were traded at around $47.00 with a P/E ratio of 24.98 and P/S ratio of 12.74. GuruFocus has detected 1 severe warning sign with Semler Scientific Inc. .
For the last quarter Semler Scientific Inc reported a revenue of $9.15 million, compared with the revenue of $5.97 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $32.8 million, an increase of 52.5% from last year. For the complete 30-year financial data, please go here.. For the last five years Semler Scientific Inc had an average revenue growth rate of 53% a year.
The reported diluted earnings per share was $1.88 for the year, compared with the loss per share of $1.72 in the previous year. The Semler Scientific Inc enjoyed an operating margin of 32.68%, compared with the operating margin of 24.86% a year before. The 10-year historical median operating margin of Semler Scientific Inc is -106.41%. The profitability rank of the company is 4 (out of 10).
At the end of the fiscal year, Semler Scientific Inc has the cash and cash equivalents of $7.74 million, compared with $3.28 million in the previous year. The company had no long term debt. The interest coverage to the debt is at a comfortable level of 5354. Semler Scientific Inc has a financial strength rank of 10 (out of 10).
For the complete 20-year historical financial data of SMLR, click here.
